Vitiligo is an acquired skin depigmentation occurring in approximately 1 percent of the population worldwide. It results from an autoimmune process directed against the melanocytes. The disease can be devastating psychologically; particularly in dark-skinned individuals. The pathogenesis is thought to involve an autoimmune process directed against melanocytes. Evidence of this is derived from histologic studies that have found an absence of melanocytes in the affected skin. An autoimmune process is also suggested by the concomitant occurrence of other autoimmune diseases in patients with vitiligo.
Many vitiligo patient hope a new method treatment for vitiligo 2017,When a patient presents with vitiligo, "It's probably the longest and most detailed consultation I do. We take a very detailed history—looking at family history, time of disease onset, disease progression, associated symptoms, associated autoimmune illnesses and medications—to tease out any other causative factors that may be contributing to pigment loss.
we need accoding to associated symptoms, associated autoimmune illnesses and medications to treat vitiligo.
UM-D treatment not only pay attention to the color restore of vitiligo, it take the advance measures to help doctor to to diagnose their immunity to see if their immune system disorder, lack of trace elements, the melanocyte condition, all kinds of antigens' condition, their skin, blood, internal organs. our treatment treat vitiligo both emphasize the inside and outside without side effects, this treatment praised by the patients from home and abroad.
